http://www.senecaglobe.com/healthcare-stocks-grab-market-attentions-gilead-sciences-nasdaqgild-pernix-therapeutics-nasdaqptx/334819/
http://www.webbreakingnews.com/2016/08/13/berson-corrado-investment-advisors-llc-has-348000-stake-in-merck-co-mrk/
http://www.dailypolitical.com/2016/08/13/richard-bernstein-advisors-llc-holds-stake-in-merck-co-mrk/
http://www.dailypolitical.com/2016/08/13/richard-bernstein-advisors-llc-holds-stake-in-merck-co-mrk-2/
http://www.dailypolitical.com/2016/08/13/merck-co-mrk-stake-lowered-by-gerber-kawasaki-wealth-investment-management/
http://www.liverpoolecho.co.uk/news/local-news/quantum-dot-firm-strikes-worldwide-11735546
http://www.4-traders.com//MERCK-LIMITED-9058973/news/Merck-Kenyan-Infertility-Victim-Gets-Support-22899353/
http://www.dailypolitical.com/2016/08/12/brokerages-set-merck-co-nysemrk-price-target-at-62-30/
http://www.webbreakingnews.com/2016/08/12/fy2017-earnings-estimate-for-merck-co-mrk-issued-by-suntrust-banks/
http://dailyguideafrica.com/kenyan-infertility-victim-gets-support/
http://www.dailypolitical.com/2016/08/11/merck-co-mrk-receives-outperform-rating-from-sanford-c-bernstein/
http://www.dailypolitical.com/2016/08/11/merck-co-mrk-price-target-raised-to-57-00/
http://www.dailypolitical.com/2016/08/11/merck-co-mrk-price-target-raised-to-57-00-2/
http://investorplace.com/2016/08/6-pharmaceuticals-stocks-to-buy-now-4/
http://www.finanznachrichten.de/nachrichten-2016-08/38286639-global-commercial-biotechnology-separation-systems-strategic-analysis-to-2020-liquid-chromatography-leads-biotechnology-separation-technologies-re-008.htm
http://www.webbreakingnews.com/2016/08/12/immune-design-corp-imdz-lifted-to-hold-at-zacks-investment-research/
http://www.prnewswire.co.uk/news-releases/research-and-markets---pneumococcal-vaccines-epidemiology-and-patient-based-market-2016-2025---prevnar-13-could-be-superseded-in-the-elderly-by-merck--cos-15-alent-conjugate-vaccine-590006831.html
http://www.4-traders.com//news/Pneumococcal-Vaccines-Epidemiology-and-Patient-Based-Market-2016-2025-Prevnar-13-will-continue-to-d--22895315/
http://www.manufacturingchemist.com/news/article_page/Novel_lipid_altering_therapies_will_steer_acute_coronary_syndrome_market_beyond_12_billion_by_2022/120271
http://www.prnewswire.co.uk/news-releases/vaccines-market-growth-83-cagr-to-2021-led-by-n-america-589956521.html
http://www.xconomy.com/san-francisco/2016/08/10/heron-gains-fda-support-for-nausea-drug-after-a-year-under-review/
http://www.bloomberg.com/news/articles/2016-08-12/astrazeneca-rides-high-fueled-by-brexit-bristol-myers-failure
http://www.latimes.com/world/global-development/la-fg-global-river-blindness-oped-snap-story.html
http://www.mmm-online.com/roundup/five-things-for-pharma-marketers-to-know-friday-august-12-2016/article/515719/
http://www.4-traders.com//news/Global-Nonstructural-Protein-4B-NS4B-Pipeline-Review-H1-2016-Gilead-Sciences-GSK-Inovio-John--22896961/
